Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study

adenoviruses are among the most promising vectors for the development of an HIV vaccine. The results of the phase IIB study of the adenovirus serotype 5-based Merck Trivalent HIV vaccine have raised the concern that serological immunity to adenovirus serotype 5 (Ad5) could be linked to HIV acquisiti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	AIDS (London) 2011-01, Vol.25 (2), p.153-158
Hauptverfasser:	CURLIN, Marcel E, CASSIS-GHAVAMI, Farah, COREY, Lawrence, MAGARET, Amalia S, SPIES, Gregory A, DUERR, Ann, CELUM, Connie L, SANCHEZ, Jorge L, MARGOLICK, Joseph B, DETELS, Roger, JULIANA MCELRATH, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoviridae Infections - blood Adenoviridae Infections - genetics Adenoviridae Infections - immunology Adenovirus Adenoviruses, Human - genetics Adenoviruses, Human - immunology Adult Africa AIDS Vaccines - blood AIDS Vaccines - immunology AIDS/HIV Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Biological and medical sciences Case-Control Studies Female Genetic Vectors Herpes simplex virus 2 HIV Seropositivity - immunology HIV-1 - pathogenicity Human immunodeficiency virus 1 Human viral diseases Humans Immunodeficiencies Immunodeficiencies. Immunoglobulinopathies Immunopathology Infectious diseases Male Medical sciences Risk Assessment South America United States Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!